181
Participants
Start Date
September 28, 2015
Primary Completion Date
April 17, 2020
Study Completion Date
December 17, 2021
Olaparib
"Olaparib Capsule - 50 mg. Olaparib capsules will be packed in high-density polyethylene (HDPE) bottles with child-resistant closures. Each bottle will contain 120 capsules and 4 bottles will be dispensed for a 4 weekly visit, with a 2 day overage.~Patients will be administered olaparib capsules orally at a dose of 400 mg twice daily.~Eight 50 mg olaparib capsules should be taken at the same time each day approximately 12 hours apart with approximately 240 mL of water."
Research Site, Budapest
Research Site, Budapest
Research Site, Budapest
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Plovdiv
Research Site, Plovdiv
Research Site, Debrecen
Research Site, Nyíregyháza
Research Site, Kecskemét
Research Site, Varna
Research Site, Prague
Research Site, Milan
Research Site, Madrid
Research Site, Madrid
Research Site, San Cristóbal de La Laguna
Research Site, Seville
Research Site, Valencia
Research Site, Valencia
Research Site, Zaragoza
Research Site, Bari
Research Site, Napoli
Research Site, Calgary
Research Site, Halifax
Research Site, London
Research Site, Toronto
Research Site, Montreal
Research Site, Montreal
Research Site, Brno
Research Site, Brno
Research Site, Nový Jičín
Research Site, Olomouc
Research Site, Ostrava
Research Site, Prague
Research Site, Perugia
Research Site, Bialystok
Research Site, Gdansk
Research Site, Kielce
Research Site, Poznan
Research Site, Poznan
Research Site, Badalona
Research Site, Barcelona
Research Site, Burgos
Research Site, L'Hospitalet de Llobregat
Research Site, Belfast
Research Site, Birmingham
Research Site, Cardiff
Research Site, Glasgow
Research Site, Leeds
Research Site, London
Research Site, Manchester
Research Site, Metropolitan Borough of Wirral
Research Site, Newcastle upon Tyne
Research Site, Oxford
Research Site, Swansea
Research Site, Taunton
Lead Sponsor
AstraZeneca
INDUSTRY